Bafna Pharmaceuticals Limited (BOM:532989)

Market Cap	2.93B +56.0%
Revenue (ttm)	1.47B -0.5%
Net Income	96.61M +124.8%
EPS	4.09 +125.1%
Shares Out	n/a
PE Ratio	30.29
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	549
Average Volume	611
Open	125.00
Previous Close	129.70
Day's Range	123.25 - 129.50
52-Week Range	67.80 - 204.95
Beta	n/a
RSI	44.37
Earnings Date	Feb 11, 2026

About Bafna Pharmaceuticals

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, Nigeria, and Commonwealth countries. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited is a subsidiary of SRJR Lifesciences LLP.

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Employees: 406
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 532989

Financial Performance

In fiscal year 2025, Bafna Pharmaceuticals's revenue was 1.46 billion, a decrease of -4.33% compared to the previous year's 1.52 billion. Earnings were 41.53 million, a decrease of -43.49%.